VERO icon

Venus Concept

2.51 USD
+0.03
1.21%
At close Apr 28, 4:00 PM EDT
After hours
2.58
+0.07
2.79%
1 day
1.21%
5 days
-5.28%
1 month
-8.73%
3 months
-29.89%
6 months
-46.93%
Year to date
-42.03%
1 year
-64.90%
5 years
-99.66%
10 years
-99.85%
 

About: Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Employees: 292

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

31% more funds holding

Funds holding: 13 [Q3] → 17 (+4) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

7.21% less ownership

Funds ownership: 24.96% [Q3] → 17.75% (-7.21%) [Q4]

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

56% less capital invested

Capital invested by funds: $1.11M [Q3] → $489K (-$617K) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for VERO.

Financial journalist opinion

Based on 8 articles about VERO published over the past 30 days

Neutral
GlobeNewsWire
2 weeks ago
Venus Concept Raises a Total of Approximately $2.7 Million in Gross Proceeds from Previously Announced Registered Direct Offerings of Common Stock
TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 386,700 shares of common stock at a purchase price of $4.06 per share.
Venus Concept Raises a Total of Approximately $2.7 Million in Gross Proceeds from Previously Announced Registered Direct Offerings of Common Stock
Neutral
GlobeNewsWire
2 weeks ago
Venus Concept Announces $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
TORONTO, April 11, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive agreements for the purchase and sale of 386,700 shares of common stock at a purchase price of $4.06 per share in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about April 14, 2025, subject to the satisfaction of customary closing conditions.
Venus Concept Announces $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Neutral
GlobeNewsWire
2 weeks ago
Venus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
TORONTO, April 10, 2025 (GLOBE NEWSWIRE) --  Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 328,573 shares of common stock at a purchase price of $3.50 per share.
Venus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Neutral
GlobeNewsWire
2 weeks ago
Venus Concept Announces $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive agreements for the purchase and sale of 328,573 shares of common stock at a purchase price of $3.50 per share in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about April 10, 2025, subject to the satisfaction of customary closing conditions.
Venus Concept Announces $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Neutral
GlobeNewsWire
3 weeks ago
Venus Concept to Release First Quarter of Fiscal Year 2025 Financial Results on May 15, 2025
TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2025 financial results will be released before the market opens on Thursday, May 15, 2025.
Venus Concept to Release First Quarter of Fiscal Year 2025 Financial Results on May 15, 2025
Neutral
GlobeNewsWire
3 weeks ago
Venus Concept Announces $11 million Debt-to-Equity Exchange Transaction
Continued improvement of the Company's financial position through additional reduction of outstanding debt by Madryn Asset Management Continued improvement of the Company's financial position through additional reduction of outstanding debt by Madryn Asset Management
Venus Concept Announces $11 million Debt-to-Equity Exchange Transaction
Neutral
Seeking Alpha
4 weeks ago
Venus Concept Inc. (VERO) Q4 2024 Earnings Conference Call Transcript
Venus Concept Inc. (NASDAQ:VERO ) Q4 2024 Earnings Conference Call March 31, 2025 8:00 AM ET Company Participants Rajiv De Silva - CEO Domenic Della Penna - EVP and CFO Conference Call Participants Marie Thibault - BTIG Jeremy Pearlman - Maxim Group Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.
Venus Concept Inc. (VERO) Q4 2024 Earnings Conference Call Transcript
Neutral
GlobeNewsWire
4 weeks ago
Venus Concept Announces Fourth Quarter and Fiscal Year 2024 Financial Results
TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2024.
Venus Concept Announces Fourth Quarter and Fiscal Year 2024 Financial Results
Neutral
GlobeNewsWire
1 month ago
Venus Concept to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025
TORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2024 financial results will be released before the market opens on Monday, March 31, 2025.
Venus Concept to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025
Neutral
GlobeNewsWire
1 month ago
Venus Concept Announces 1-for-11 Reverse Stock Split
TORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it will effect a 1-for-11 reverse stock split of the Company's issued and outstanding common stock (the “Reverse Stock Split”). The Reverse Stock Split will be effective at 5:00 p.m. Eastern Standard Time on March 3, 2025. The Company's common stock is expected to begin trading on The Nasdaq Capital Market on a split-adjusted basis at the open of trading on March 4, 2025.
Venus Concept Announces 1-for-11 Reverse Stock Split
Charts implemented using Lightweight Charts™